Binding of daunomycin to diaminopurine- and/or inosine-substituted DNA

被引:26
作者
Bailly, C
Suh, D
Waring, MJ
Chaires, JB
机构
[1] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA
[2] INSERM U124, F-59045 Lille, France
[3] Ctr Oscar Lambret, Lab Pharmacol Antitumorale Mol, F-59045 Lille, France
[4] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England
基金
英国惠康基金;
关键词
D O I
10.1021/bi9716128
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The binding of the anticancer drug daunomycin to double-helical DNA has been investigated by DNase I footprinting and fluorescence titration, using a series of polymerase chain reaction (PCR) synthesized DNA fragments that contained systematic base substitutions to alter the disposition of functional groups within the minor groove, The 160 bp tyrT DNA fragment constituted the starting material. Fragments in which (i) inosine was substituted for guanosine, (ii) diaminopurine was substituted for adenine, and (iii) both inosine and diaminopurine were substituted for guanosine and adenine, respectively, were studied. These fragments permit the role of the 2-amino group in the minor groove to be systematically explored. The results of DNase I footprinting experiments confirmed that daunomycin binds preferentially to 5'(A/T)GC and S'(A/T)CG triplets in the normal fragment. Substitution of inosine for guanosine, with the concomitant loss of the N-2 in the minor groove, weakened binding affinity but did not dramatically alter the sequence preference associated with daunomycin binding. Complete reversal of the location of the N-2 group by the double substitution, however, completely altered the sequence preference of daunomycin and shifted its binding from the canonical triplets to ones with a 5'IDD motif, These results have critically tested and confirmed the proposed key roles of the daunosamine moiety and the 9-OH group of daunomycin in dictating binding to preferred sites, In a parallel study, both macroscopic and microscopic binding to the normal tyrT fragment were investigated, experiments made possible by using PCR to prepare large quantities of the long, defined DNA sequence, The results of these experiments underscored the complexity of the interaction of the drug with the DNA lattice and revealed unequivocal heterogeneity in its affinity for different binding sites, A class of high-affinity sites, most probably corresponding to the S'(A/T)GC and S'(A/T)CG triplets, was identified and characterized in macroscopic binding isotherms.
引用
收藏
页码:1033 / 1045
页数:13
相关论文
共 37 条
[31]  
PULLMAN B, 1990, ANTI-CANCER DRUG DES, V7, P95
[32]   FOOTPRINTING TITRATION STUDIES ON THE BINDING OF ECHINOMYCIN TO DNA INCAPABLE OF FORMING HOOGSTEEN BASE-PAIRS [J].
SAYERS, EW ;
WARING, MJ .
BIOCHEMISTRY, 1993, 32 (35) :9094-9107
[33]  
Shubsda Michael, 1994, Journal of Molecular Recognition, V7, P133, DOI 10.1002/jmr.300070210
[34]   QUANTITATIVE FOOTPRINTING ANALYSIS OF THE CHROMOMYCIN-A3-DNA INTERACTION [J].
STANKUS, A ;
GOODISMAN, J ;
DABROWIAK, JC .
BIOCHEMISTRY, 1992, 31 (38) :9310-9318
[35]   QUANTITATIVE FOOTPRINTING ANALYSIS OF THE NETROPSIN-DNA INTERACTION [J].
WARD, B ;
REHFUSS, R ;
DABROWIAK, JC .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 1987, 4 (05) :685-695
[36]  
Waring Michael J., 1994, Journal of Molecular Recognition, V7, P109, DOI 10.1002/jmr.300070208
[37]   THE PURINE 2-AMINO GROUP AS A CRITICAL RECOGNITION ELEMENT FOR BINDING OF SMALL MOLECULES TO DNA [J].
WARING, MJ ;
BAILLY, CB .
GENE, 1994, 149 (01) :69-79